Market revenue in 2022 | USD 180.1 million |
Market revenue in 2030 | USD 252.8 million |
Growth rate | 4.3% (CAGR from 2022 to 2030) |
Largest segment | Reagents & consumables |
Fastest growing segment | Analyzers |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Analyzers, Reagents & Consumables |
Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.52% in 2022. Horizon Databook has segmented the Brazil thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing prevalence of blood clotting disorders & CVDs in the population, healthcare spending, and the availability of diagnostic tests & treatments are expected to boost the market. For instance, according to a study by Global Disease Burden (GDB) in 2019, CVDs are the main cause of death in Brazil.
Chronic disease prevalence is high in this country due to the moderate standards of living, which increases the need for advanced diagnostic & treatment options. It has been found that infectious diseases are a major cause of death in Brazil.
Hence, public & private organizations need to undertake initiatives to reduce the mortality rate by improving early diagnosis rates with the use of thrombosis biomarkers. The rise in the number of partnerships & collaborations between private & public institutes and manufacturers for research on thrombosis and hemostasis biomarkers is driving the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Brazil thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account